Back to search
FDAFDA · Food and drugs·Recall number D-0012-2021

Cephalexin for Oral Suspension, USP 125 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, a) 100 mL bottle when mixed, NDC 0093-4175-73, b) 200 mL bottle when mixed, NDC 0093-4175-74, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.

Published September 16, 2020 · Recall initiated: August 24, 2020

Summary

FDA records drug Class II recall D-0012-2021, published September 16, 2020 and initiated August 24, 2020. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 103,940 bottles; Lot: Lot #s: a) 30309820A, Exp. 08/2020; 30310000B, 30310001B, Exp. 10/2020; 30310096A Exp. 01/2021; 30310228A, Exp. 03/2021; 30310313A, Exp. 06/2021; b) 30309861A, Exp. 08/2020; 30310335A, Exp. 06/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.

What to do

Voluntary: Firm initiated · Letter

Get an email if CEPHALEXIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CEPHALEXIN
Manufacturer
Teva Pharmaceuticals USA
Distributor
Nationwide in the U.S. and Puerto Rico.
UPC
0300934175738
Lot
Lot #s: a) 30309820A, Exp. 08/2020; 30310000B, 30310001B, Exp. 10/2020; 30310096A Exp. 01/2021; 30310228A, Exp. 03/2021; 30310313A, Exp. 06/2021; b) 30309861A, Exp. 08/2020; 30310335A, Exp. 06/2021.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cephalexin for Oral Suspension, USP 125 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, a) 100 mL bottle when mixed, NDC 0093-4175-73, b) 200 mL bottle when mixed, NDC 0093-4175-74, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454. recalled?

Yes. FDA published recall D-0012-2021 on September 16, 2020. Reported hazard: CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CEPHALEXIN. UPC: 0300934175738.